FABP4 and Schnyder corneal dystrophy: Despite these limitations, our study has numerous strengths including a large sample size; a representative sample of older adults; inclusion of both men and women; the use of a valid and reproducible method to assess FABP4; a validation of SCD by cardiologists; availability of data on numerous potential confounders; and long-term and nearly complete followup.